Literature DB >> 8195132

The mRNA (guanine-7-)methyltransferase domain of the vaccinia virus mRNA capping enzyme. Expression in Escherichia coli and structural and kinetic comparison to the intact capping enzyme.

M A Higman1, L A Christen, E G Niles.   

Abstract

The mRNA (guanine-7-)methyltransferase active site of the heterodimeric vaccinia virus mRNA capping enzyme was previously localized to the carboxyl-terminal third of the large subunit, D1R, associated with the small subunit, D12L (Cong, P., and Shuman, S. (1992) J. Biol. Chem. 267, 16424-16429; Higman, M. A., Bourgeois, N., and Niles, E. G. (1992) J. Biol. Chem. 267, 16430-16437). A plasmid was constructed which directs the coexpression of the carboxyl terminus of the D1R subunit from amino acids 498 to 844 and the D12L subunit in Escherichia coli. The mRNA (guanine-7-)methyltransferase catalytic activity in the isolated domain was found to be kinetically equivalent to that present in the intact enzyme. Through mobility shift and ultraviolet photolinkage analyses, both domains were shown to bind RNA in a saturable fashion. RNA binding was localized predominantly to the large subunit, but a low level of linkage of RNA to D12L was also observed. A low, but reproducible, level of mRNA (guanine-7-)methyltransferase activity was detected in the isolated D1R498-844 subunit demonstrating that the active site resides solely within the large subunit of the capping enzyme. This activity is enhanced 30- to 50-fold by the association of the D12L subunit.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195132

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Phylogeny of mRNA capping enzymes.

Authors:  S P Wang; L Deng; C K Ho; S Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

Review 2.  Enzymology of RNA cap synthesis.

Authors:  Agnidipta Ghosh; Christopher D Lima
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-25       Impact factor: 9.957

3.  Structural insights into the mechanism and evolution of the vaccinia virus mRNA cap N7 methyl-transferase.

Authors:  Marcos De la Peña; Otto J P Kyrieleis; Stephen Cusack
Journal:  EMBO J       Date:  2007-11-08       Impact factor: 11.598

4.  Phenotypic analysis of a temperature sensitive mutant in the large subunit of the vaccinia virus mRNA capping enzyme.

Authors:  Amber N Shatzer; Sayuri E M Kato; Richard C Condit
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

5.  The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure.

Authors:  Moheshwarnath Issur; Brian J Geiss; Isabelle Bougie; Frédéric Picard-Jean; Simon Despins; Joannie Mayette; Sarah E Hobdey; Martin Bisaillon
Journal:  RNA       Date:  2009-10-22       Impact factor: 4.942

6.  A yeast-based genetic system for functional analysis of viral mRNA capping enzymes.

Authors:  C K Ho; A Martins; S Shuman
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

7.  The LEF-4 subunit of baculovirus RNA polymerase has RNA 5'-triphosphatase and ATPase activities.

Authors:  J Jin; W Dong; L A Guarino
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

8.  Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures.

Authors:  Erwin van Dijk; Nicolas Cougot; Sylke Meyer; Sylvie Babajko; Elmar Wahle; Bertrand Séraphin
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

9.  Genetic, physical, and functional interactions between the triphosphatase and guanylyltransferase components of the yeast mRNA capping apparatus.

Authors:  C K Ho; B Schwer; S Shuman
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  Vaccinia virus early gene transcription termination factors VTF and Rap94 interact with the U9 termination motif in the nascent RNA in a transcription ternary complex.

Authors:  Linda A Christen; Sarah Piacente; Mohamed R Mohamed; Edward G Niles
Journal:  Virology       Date:  2008-05-01       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.